A critical role for the cholesterol-associated proteolipids PLP and M6B in myelination of the central nervous system

GLIA

Volumn 61, Issue 4, 2013, Pages 567-586

  Werner, Hauke B ^a   Krämer Albers, Eva Maria ^b   Strenzke, Nicola ^c   Saher, Gesine ^a   Tenzer, Stefan ^d   Ohno Iwashita, Yoshiko ^e   De Monasterio Schrader, Patricia ^a   Möbius, Wiebke ^a   Moser, Tobias ^c   Griffiths, Ian R ^f   Nave, Klaus Armin ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e IWAKI MEISEI UNIVERSITY   (Japan)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cholesterol; Leukodystrophy; Myelin biogenesis; Myelin proteome; Oligodendrocyte; Pelizaeus Merzbacher disease; Spastic paraplegia

Indexed keywords

CHOLESTEROL; GLYCOPROTEIN; GLYCOPROTEIN M6B; MYELIN; PROTEOLIPID; RNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; BIOGENESIS; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; MASS SPECTROMETER; MICROGLIA; MOLECULAR CLONING; MOLECULAR GENETICS; MOTOR PERFORMANCE; MOUSE; MYELINATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; CELL LINE; CENTRAL NERVOUS SYSTEM; CHOLESTEROL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; EVOKED POTENTIALS, VISUAL; MEMBRANE GLYCOPROTEINS; MICE; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; NERVE TISSUE PROTEINS; VOMERONASAL ORGAN;

EID: 84873721021     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22456     Document Type: Article

References (76)

1. Birling MC, Tait S, Hardy RJ, Brophy PJ. 1999. A novel rat tetraspan protein in cells of the oligodendrocyte lineage. J Neurochem 73: 2600-2608.
2. Bosse F, Hasse B, Pippirs U, Greiner-Petter R, Muller HW. 2003. Proteolipid plasmolipin: Localization in polarized cells, regulated expression and lipid raft association in CNS and PNS myelin. J Neurochem 86: 508-518.
3. Burgisser P, Matthieu JM, Jeserich G, Waehneldt TV. 1986. Myelin lipids: A phylogenetic study. Neurochem Res 11: 1261-1272.
4. Buser AM, Erne B, Werner HB, Nave KA, Schaeren-Wiemers N. 2009. The septin cytoskeleton in myelinating glia. Mol Cell Neurosci 40: 156-166.
5. Cammer W, Fredman T, Rose AL, Norton WT. 1976. Brain carbonic anhydrase: Activity in isolated myelin and the effect of hexachlorophene. J Neurochem 27: 165-171.
6. Castells X, Acebes JJ, Boluda S, Moreno-Torres A, Pujol J, Julia-Sape M, Candiota AP, Arino J, Barcelo A, Arus C. 2010. Development of a predictor for human brain tumors based on gene expression values obtained from two types of microarray technologies. Omics 14: 157-164.
7. Charrin S, Manie S, Thiele C, Billard M, Gerlier D, Boucheix C, Rubinstein E. 2003. A physical and functional link between cholesterol and tetraspanins. Eur J Immunol 33: 2479-2489.
8. Chrast R, Saher G, Nave KA, Verheijen MH. 2011. Lipid metabolism in myelinating glial cells: Lessons from human inherited disorders and mouse models. J Lipid Res 52: 419-434.
9. Claas C, Stipp CS, Hemler ME. 2001. Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J Biol Chem 276: 7974-7984.
10. Dangond F, Hwang D, Camelo S, Pasinelli P, Frosch MP, Stephanopoulos G, Brown RHJr., Gullans SR. 2004. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genomics 16: 229-239.
11. Dhaunchak AS, Nave KA. 2007. A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease. Proc Natl Acad Sci USA 104: 17813-17818.
12. Duncan ID. 2005. The PLP mutants from mouse to man. J Neurol Sci 228: 204-205.
13. Edgar JM, McLaughlin M, Werner HB, McCulloch MC, Barrie JA, Brown A, Faichney AB, Snaidero N, Nave KA, Griffiths IR. 2009. Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. Glia 57: 1815-1824.
14. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, Montague P, Barrie JA, McCulloch MC, Duncan ID, Garbern J, Nave KA, Griffiths IR. 2004. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166: 121-131.
15. Eiberger J, Kibschull M, Strenzke N, Schober A, Bussow H, Wessig C, Djahed S, Reucher H, Koch DA, Lautermann J, Moser T, Winterhager E, Willecke K. 2006. Expression pattern and functional characterization of connexin29 in transgenic mice. Glia 53: 601-611.
16. Epand RM. 2006. Cholesterol and the interaction of proteins with membrane domains. Prog Lipid Res 45: 279-294.
17. Feldmann A, Winterstein C, White R, Trotter J, Kramer-Albers EM. 2009. Comprehensive analysis of expression, subcellular localization, and cognate pairing of SNARE proteins in oligodendrocytes. J Neurosci Res 87: 1760-1772.
18. Fiori LM, Zouk H, Himmelman C, Turecki G. 2011. X chromosome and suicide. Mol Psychiatry 16: 216-226.
19. Garbern JY. 2007. Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis. Cell Mol Life Sci 64: 50-65.
20. Gielen E, Baron W, Vandeven M, Steels P, Hoekstra D, Ameloot M. 2006. Rafts in oligodendrocytes: Evidence and structure-function relationship. Glia 54: 499-512.
21. Gitik M, Liraz-Zaltsman S, Oldenborg PA, Reichert F, Rotshenker S. 2011. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPalpha (signal regulatory protein-alpha) on phagocytes. J Neuroinflammation 8: 24.
22. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, Danias J, Bronstein JM, Kachar B, Lazzarini RA. 1999. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 99: 649-659.
23. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280: 1610-1613.
24. Huttner WB, Zimmerberg J. 2001. Implications of lipid microdomains for membrane curvature, budding and fission. Curr Opin Cell Biol 13: 478-484.
25. Jahn O, Tenzer S, Werner HB. 2009. Myelin proteomics: Molecular anatomy of an insulating sheath. Mol Neurobiol 40: 55-72.
26. Johns TG, Bernard CC. 1999. The structure and function of myelin oligodendrocyte glycoprotein. J Neurochem 72: 1-9.
27. Jung M, Sommer I, Schachner M, Nave KA. 1996. Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): Evidence that PLP misfolding underlies dysmyelination in mutant mice. J Neurosci 16: 7920-7929.
28. Jung M, Crang AJ, Blakemore WF, Hoppe D, Kettenmann H, Trotter J. 1994. In vitro and in vivo characterisation of glial cells immortalised with a temperature sensitive SV40 T antigen-containing retrovirus. J Neurosci Res 37: 182-196.
29. Jurevics H, Hostettler J, Sammond DW, Nave KA, Toews AD, Morell P. 2003. Normal metabolism but different physical properties of myelin from mice deficient in proteolipid protein. J Neurosci Res 71: 826-834.
30. Kagawa T, Mekada E, Shishido Y, Ikenaka K. 1997. Immune system-related CD9 is expressed in mouse central nervous system myelin at a very late stage of myelination. J Neurosci Res 50: 312-320.
31. Keller RK, Small M, Fliesler SJ. 2004. Enzyme blockade: A nonradioactive method to determine the absolute rate of cholesterol synthesis in the brain. J Lipid Res 45: 1952-1957.
32. Kirschner DA, Inouye H, Ganser AL, Mann V. 1989. Myelin membrane structure and composition correlated: A phylogenetic study. J Neurochem 53: 1599-1609.
33. Klugmann M, Schwab MH, Puhlhofer A, Schneider A, Zimmermann F, Griffiths IR, Nave KA. 1997. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18: 59-70.
34. Kramer EM, Schardt A, Nave KA. 2001. Membrane traffic in myelinating oligodendrocytes. Microsc Res Technol 52: 656-671.
35. Krämer-Albers E-M, Bretz N, Tenzer S, Winterstein C, Möbius W, Berger H, Nave K-A, Schild H, Trotter J. 2007. Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: Trophic support for axons? Proteomics Clin Appl 1: 1446-1461.
36. Krämer-Albers EM, Gehrig-Burger K, Thiele C, Trotter J, Nave KA. 2006. Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligodendroglia: Implications for dysmyelination in spastic paraplegia. J Neurosci 26: 11743-11752.
37. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33: 366-374.
38. Magal LG, Yaffe Y, Shepshelovich J, Aranda JF, de Marco Mdel C, Gaus K, Alonso MA, Hirschberg K. 2009. Clustering and lateral concentration of raft lipids by the MAL protein. Mol Biol Cell 20: 3751-3762.
39. Maxfield FR, van Meer G. 2010. Cholesterol, the central lipid of mammalian cells. Curr Opin Cell Biol 22: 422-429.
40. Mela A, Goldman JE. 2009. The tetraspanin KAI1/CD82 is expressed by late-lineage oligodendrocyte precursors and may function to restrict precursor migration and promote oligodendrocyte differentiation and myelination. J Neurosci 29: 11172-11181.
41. Miller MJ, Haxhiu MA, Georgiadis P, Gudz TI, Kangas CD, Macklin WB. 2003. Proteolipid protein gene mutation induces altered ventilatory response to hypoxia in the myelin-deficient rat. J Neurosci 23: 2265-2273.
42. Mimault C, Giraud G, Courtois V, Cailloux F, Boire JY, Dastugue B, Boespflug-Tanguy O. 1999. Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: Duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease. Am J Hum Genet 65: 360-369.
43. Mobius W, Patzig J, Nave KA, Werner HB. 2008. Phylogeny of proteolipid proteins: divergence, constraints, and the evolution of novel functions in myelination and neuroprotection. Neuron Glia Biol 4: 111-127.
44. Morell P, Jurevics H. 1996. Origin of cholesterol in myelin. Neurochem Res 21: 463-470.
45. Nave KA. 2010. Myelination and support of axonal integrity by glia. Nature 468: 244-252.
46. Nawaz S, Kippert A, Saab AS, Werner HB, Lang T, Nave KA, Simons M. 2009. Phosphatidylinositol 4, 5-bisphosphate-dependent interaction of myelin basic protein with the plasma membrane in oligodendroglial cells and its rapid perturbation by elevated calcium. J Neurosci 29: 4794-4807.
47. Norton WT, Poduslo SE. 1973. Myelination in rat brain: Changes in myelin composition during brain maturation. J Neurochem 21: 759-773.
48. O'Brien JS. 1965. Stability of the Myelin Membrane. Science 147: 1099-1107.
49. Patzig J, Jahn O, Tenzer S, Wichert SP, de Monasterio-Schrader P, Rosfa S, Kuharev J, Yan K, Bormuth I, Bremer J, Aguzzi A, Orfaniotou F, Hesse D, Schwab MH, Mobius W, Nave KA, Werner HB. 2011. Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J Neurosci 31: 16369-16386.
50. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. 2001. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57: 1618-1628.
51. Quarles RH. 2007. Myelin-associated glycoprotein (MAG): Past, present and beyond. J Neurochem 100: 1431-1448.
52. Ramnarayanan SP, Tuma PL. 2011. MAL, but not MAL2, expression promotes the formation of cholesterol-dependent membrane domains that recruit apical proteins. Biochem J 439: 497-504.
53. Saher G, Quintes S, Mobius W, Wehr MC, Kramer-Albers EM, Brugger B, Nave KA. 2009. Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction. J Neurosci 29: 6094-6104.
54. Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, Nave KA. 2005. High cholesterol level is essential for myelin membrane growth. Nat Neurosci 8: 468-475.
55. Saher G, Rudolphi F, Corthals K, Ruhwedel T, Schmidt KF, Lowel S, Dibaj P, Barrette B, Mobius W, Nave KA. 2012. Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet. Nat Med 18: 1130-1135.
56. Saravanan K, Schaeren-Wiemers N, Klein D, Sandhoff R, Schwarz A, Yaghootfam A, Gieselmann V, Franken S. 2004. Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder. Neurobiol Dis 16: 396-406.
57. Schaeren-Wiemers N, Bonnet A, Erb M, Erne B, Bartsch U, Kern F, Mantei N, Sherman D, Suter U. 2004. The raft-associated protein MAL is required for maintenance of proper axon-glia interactions in the central nervous system. J Cell Biol 166: 731-742.
58. Schweitzer J, Becker T, Schachner M, Nave KA, Werner H. 2006. Evolution of myelin proteolipid proteins: gene duplication in teleosts and expression pattern divergence. Mol Cell Neurosci 31: 161-177.
59. Simons K, Ikonen E. 1997. Functional rafts in cell membranes. Nature 387: 569-572.
60. Simons M, Trotter J. 2007. Wrapping it up: the cell biology of myelination. Curr Opin Neurobiol 17: 533-540.
61. Simons M, Kramer EM, Thiele C, Stoffel W, Trotter J. 2000. Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J Cell Biol 151: 143-154.
62. Sons MS, Busche N, Strenzke N, Moser T, Ernsberger U, Mooren FC, Zhang W, Ahmad M, Steffens H, Schomburg ED, Plomp JJ, Missler M. 2006. alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction. Neuroscience 138: 433-446.
63. Takamori S, Holt M, Stenius K, Lemke EA, Grønborg M, Riedel D, Urlaub H, Schenck S, Brügger B, Ringler P, Müller SA, Rammner B, Gräter F, Hub JS, De Groot BL, Mieskes G, Moriyama Y, Klingauf J, Grubmüller H, Heuser J, Wieland F, Jahn R. 2006. Molecular anatomy of a trafficking organelle. Cell 127: 831-846.
64. Terada N, Baracskay K, Kinter M, Melrose S, Brophy PJ, Boucheix C, Bjartmar C, Kidd G, Trapp BD. 2002. The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to beta1 integrin, CD81, and Tspan-2. Glia 40: 350-359.
65. Thiele C, Hannah MJ, Fahrenholz F, Huttner WB. 2000. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol 2: 42-49.
66. Thurnherr T, Benninger Y, Wu X, Chrostek A, Krause SM, Nave KA, Franklin RJ, Brakebusch C, Suter U, Relvas JB. 2006. Cdc42 and Rac1 signaling are both required for and act synergistically in the correct formation of myelin sheaths in the CNS. J Neurosci 26: 10110-10119.
67. Trapp BD, Nishiyama A, Cheng D, Macklin W. 1997. Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 137: 459-468.
68. van Meer G, Voelker DR, Feigenson GW. 2008. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9: 112-124.
69. Waheed AA, Shimada Y, Heijnen HF, Nakamura M, Inomata M, Hayashi M, Iwashita S, Slot JW, Ohno-Iwashita Y. 2001. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc Natl Acad Sci USA 98: 4926-4931.
70. Wang E, Dimova N, Sperle K, Huang Z, Lock L, McCulloch MC, Edgar JM, Hobson GM, Cambi F. 2008. Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability. Exp Neurol 214: 322-330.
71. Werner H, Dimou L, Klugmann M, Pfeiffer S, Nave KA. 2001. Multiple splice isoforms of proteolipid M6B in neurons and oligodendrocytes. Mol Cell Neurosci 18: 593-605.
72. Werner H, Jung M, Klugmann M, Sereda M, Griffiths IR, Nave KA. 1998. Mouse models of myelin diseases. Brain Pathol 8: 771-793.
73. Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, Dimova K, Orfaniotou F, Dhaunchak A, Brinkmann BG, Mobius W, Guarente L, Casaccia-Bonnefil P, Jahn O, Nave KA. 2007. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci 27: 7717-7730.
74. Yan Y, Lagenaur C, Narayanan V. 1993. Molecular cloning of M6: Identification of a PLP/DM20 gene family. Neuron 11: 423-431.
75. Yin X, Baek RC, Kirschner DA, Peterson A, Fujii Y, Nave KA, Macklin WB, Trapp BD. 2006. Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol 172: 469-478.
76. Yoshida M, Colman DR. 1996. Parallel evolution and coexpression of the proteolipid proteins and protein zero in vertebrate myelin. Neuron 16: 1115-1126.